The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global IVD Infectious Disease Market Research Report 2025
Synopsis
In Vitro Diagnosis, or IVD (In Vitro Diagnosis), refers to the product and service of disease or body function that is obtained by testing human samples (blood, body fluids, tissues, etc.).
The global IVD Infectious Disease market was valued at US$ 4364 million in 2023 and is anticipated to reach US$ 7765.1 million by 2030, witnessing a CAGR of 8.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for IVD Infectious Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVD Infectious Disease.
Report Scope
The IVD Infectious Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global IVD Infectious Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IVD Infectious Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Diagnostics
Abbott Laboratories
Gen-Probe
Becton Dickinson (BD)
Bio-Rad Laboratories
Siemens Healthcare
Biomérieux
Danaher
Thermo Fisher
Sysmex
Segment by Type
Biochemical Diagnosis
Immune Diagnosis
Molecular Diagnosis
Microbiological Diagnosis
Urine Diagnosis
Coagulation Diagnosis
Other
Segment by Application
Personal
Commercial
Academic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IVD Infectious Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In Vitro Diagnosis, or IVD (In Vitro Diagnosis), refers to the product and service of disease or body function that is obtained by testing human samples (blood, body fluids, tissues, etc.).
The global IVD Infectious Disease market was valued at US$ 4364 million in 2023 and is anticipated to reach US$ 7765.1 million by 2030, witnessing a CAGR of 8.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for IVD Infectious Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVD Infectious Disease.
Report Scope
The IVD Infectious Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global IVD Infectious Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IVD Infectious Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Diagnostics
Abbott Laboratories
Gen-Probe
Becton Dickinson (BD)
Bio-Rad Laboratories
Siemens Healthcare
Biomérieux
Danaher
Thermo Fisher
Sysmex
Segment by Type
Biochemical Diagnosis
Immune Diagnosis
Molecular Diagnosis
Microbiological Diagnosis
Urine Diagnosis
Coagulation Diagnosis
Other
Segment by Application
Personal
Commercial
Academic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IVD Infectious Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IVD Infectious Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Biochemical Diagnosis
1.2.3 Immune Diagnosis
1.2.4 Molecular Diagnosis
1.2.5 Microbiological Diagnosis
1.2.6 Urine Diagnosis
1.2.7 Coagulation Diagnosis
1.2.8 Other
1.3 Market by Application
1.3.1 Global IVD Infectious Disease Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Personal
1.3.3 Commercial
1.3.4 Academic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global IVD Infectious Disease Market Perspective (2019-2030)
2.2 IVD Infectious Disease Growth Trends by Region
2.2.1 Global IVD Infectious Disease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 IVD Infectious Disease Historic Market Size by Region (2019-2024)
2.2.3 IVD Infectious Disease Forecasted Market Size by Region (2025-2030)
2.3 IVD Infectious Disease Market Dynamics
2.3.1 IVD Infectious Disease Industry Trends
2.3.2 IVD Infectious Disease Market Drivers
2.3.3 IVD Infectious Disease Market Challenges
2.3.4 IVD Infectious Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IVD Infectious Disease Players by Revenue
3.1.1 Global Top IVD Infectious Disease Players by Revenue (2019-2024)
3.1.2 Global IVD Infectious Disease Revenue Market Share by Players (2019-2024)
3.2 Global IVD Infectious Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by IVD Infectious Disease Revenue
3.4 Global IVD Infectious Disease Market Concentration Ratio
3.4.1 Global IVD Infectious Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVD Infectious Disease Revenue in 2023
3.5 IVD Infectious Disease Key Players Head office and Area Served
3.6 Key Players IVD Infectious Disease Product Solution and Service
3.7 Date of Enter into IVD Infectious Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IVD Infectious Disease Breakdown Data by Type
4.1 Global IVD Infectious Disease Historic Market Size by Type (2019-2024)
4.2 Global IVD Infectious Disease Forecasted Market Size by Type (2025-2030)
5 IVD Infectious Disease Breakdown Data by Application
5.1 Global IVD Infectious Disease Historic Market Size by Application (2019-2024)
5.2 Global IVD Infectious Disease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America IVD Infectious Disease Market Size (2019-2030)
6.2 North America IVD Infectious Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America IVD Infectious Disease Market Size by Country (2019-2024)
6.4 North America IVD Infectious Disease Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe IVD Infectious Disease Market Size (2019-2030)
7.2 Europe IVD Infectious Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe IVD Infectious Disease Market Size by Country (2019-2024)
7.4 Europe IVD Infectious Disease Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific IVD Infectious Disease Market Size (2019-2030)
8.2 Asia-Pacific IVD Infectious Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific IVD Infectious Disease Market Size by Region (2019-2024)
8.4 Asia-Pacific IVD Infectious Disease Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America IVD Infectious Disease Market Size (2019-2030)
9.2 Latin America IVD Infectious Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America IVD Infectious Disease Market Size by Country (2019-2024)
9.4 Latin America IVD Infectious Disease Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IVD Infectious Disease Market Size (2019-2030)
10.2 Middle East & Africa IVD Infectious Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa IVD Infectious Disease Market Size by Country (2019-2024)
10.4 Middle East & Africa IVD Infectious Disease Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Detail
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics IVD Infectious Disease Introduction
11.1.4 Roche Diagnostics Revenue in IVD Infectious Disease Business (2019-2024)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories IVD Infectious Disease Introduction
11.2.4 Abbott Laboratories Revenue in IVD Infectious Disease Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 Gen-Probe
11.3.1 Gen-Probe Company Detail
11.3.2 Gen-Probe Business Overview
11.3.3 Gen-Probe IVD Infectious Disease Introduction
11.3.4 Gen-Probe Revenue in IVD Infectious Disease Business (2019-2024)
11.3.5 Gen-Probe Recent Development
11.4 Becton Dickinson (BD)
11.4.1 Becton Dickinson (BD) Company Detail
11.4.2 Becton Dickinson (BD) Business Overview
11.4.3 Becton Dickinson (BD) IVD Infectious Disease Introduction
11.4.4 Becton Dickinson (BD) Revenue in IVD Infectious Disease Business (2019-2024)
11.4.5 Becton Dickinson (BD) Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Detail
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories IVD Infectious Disease Introduction
11.5.4 Bio-Rad Laboratories Revenue in IVD Infectious Disease Business (2019-2024)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Siemens Healthcare
11.6.1 Siemens Healthcare Company Detail
11.6.2 Siemens Healthcare Business Overview
11.6.3 Siemens Healthcare IVD Infectious Disease Introduction
11.6.4 Siemens Healthcare Revenue in IVD Infectious Disease Business (2019-2024)
11.6.5 Siemens Healthcare Recent Development
11.7 Biomérieux
11.7.1 Biomérieux Company Detail
11.7.2 Biomérieux Business Overview
11.7.3 Biomérieux IVD Infectious Disease Introduction
11.7.4 Biomérieux Revenue in IVD Infectious Disease Business (2019-2024)
11.7.5 Biomérieux Recent Development
11.8 Danaher
11.8.1 Danaher Company Detail
11.8.2 Danaher Business Overview
11.8.3 Danaher IVD Infectious Disease Introduction
11.8.4 Danaher Revenue in IVD Infectious Disease Business (2019-2024)
11.8.5 Danaher Recent Development
11.9 Thermo Fisher
11.9.1 Thermo Fisher Company Detail
11.9.2 Thermo Fisher Business Overview
11.9.3 Thermo Fisher IVD Infectious Disease Introduction
11.9.4 Thermo Fisher Revenue in IVD Infectious Disease Business (2019-2024)
11.9.5 Thermo Fisher Recent Development
11.10 Sysmex
11.10.1 Sysmex Company Detail
11.10.2 Sysmex Business Overview
11.10.3 Sysmex IVD Infectious Disease Introduction
11.10.4 Sysmex Revenue in IVD Infectious Disease Business (2019-2024)
11.10.5 Sysmex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
